Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications
- 24 May 2004
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 94 (1-2) , 11-26
- https://doi.org/10.1016/j.imlet.2004.04.015
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsBlood, 2004
- Frontline: Neuropilin‐1: a surface marker of regulatory T cellsEuropean Journal of Immunology, 2004
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeEuropean Journal of Immunology, 2004
- Dendritic cells: emerging pharmacological targets of immunosuppressive drugsNature Reviews Immunology, 2004
- High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cellsTransplant Immunology, 2003
- Regulatory T cells in transplantation toleranceNature Reviews Immunology, 2003
- Regulatory T cells under scrutinyNature Reviews Immunology, 2003
- Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage1Transplantation, 2002
- CD4+CD25+ Immunoregulatory T CellsThe Journal of Experimental Medicine, 2002
- Infectious ToleranceThe Journal of Experimental Medicine, 2002